- ArcelorMittal Sees Gradual Upturn After Quarterly Loss
- Biggest IPO Sparks Fear of China Market Bubble
- Santander Net Profit Drops 4.5%, Beats Forecasts
- Honda Posts Surprise Quarterly Profit, Raises Forecast
- Nomura Posts First Profit in 6 Quarters, Tops Forecasts
- Car Bomb Injures 49 at Spanish Police Barracks
- CFTC Seen Clamping Down on Energy Speculation
- Beyond Earnings: Five Things Investors Will Be Watching
- Foreign Demand at 2-Year Treasury Auction Disappoints
- Administration Takes Loan Servicers to Task
- Signs of Hope in California Housing
- Assessing Swimwear Ruling With Speedo's Craig Brommers
- GE Shares Could Double in 3 Years: Analyst
- Pros Say: Recession Won't Have a Second Dip
- Corporation or Personality Cult?
- Sponsor Strategy On Vick: Stay Quiet
- Silver Safer Than Gold, Natural Gas: Commodity Exec
- Paying Overtime to Cover Furloughs
- Nissan reports loss for fiscal first quarter
- UK mortgage approvals at 14-month high in June
- Taiwan chipmaker UMC returns to profit in Q2
- Wolters Kluwer profit falls 8 percent in H1
- UK lending growth slows in June
- Scientists seek new tools to fight malnutrition
- Spain's Santander Q2 net profit down 4 pct
- Randstad profit down 89 percent in 2Q
- Toshiba quarterly loss swells to $614 million
Biogen Idec co-founder retiring from board
Text Size 
CAMBRIDGE, Mass. - Biotechnology company Biogen Idec Inc. said Thursday co-founder Phillip A. Sharp will retire from the board of directors.
Sharp, 65, co-founded Biogen in 1978 and has been a director since 1982.
He was awarded a Nobel Prize in Medicine in 1993 and was a National Medal of Science recipient in 2006.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes